ACTRN12620000526976招募中未知
Evaluation of Point Of Care Hepatitis C testing and subsequent treatment uptake in injecting drug users visiting a medically Supervised Injecting Room – a pilot study (EPOCH-SIR)
Gastroenterology Department, St Vincent's Hospital Melbourne0 个研究点目标入组 1,500 人开始时间: 2020年4月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 1,500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit(—)
- 性别
- All
入选标准
- •Aged greater than or equal to 18 years;
- •- Present to the medically supervised injecting room during the recruitment phase of the study;
- •- Able to provide written informed consent;
- •- Consent to provide full name, contact details and Medicare number;
- •- Consent to multiple visits and to completion of questionnaires;
- •- Consent to blood sample for storage at pre-specified time points during the study;
- •- Not currently engaged in care for treatment of hepatitis C infection, hepatitis B or HIV;
- •- Fulfills study criteria for hepatitis C diagnosis to initiate treatment.
排除标准
- •- Pregnant or breastfeeding at time of commencement of hepatitis C antiviral treatment;
- •- Clinical evidence of decompensated cirrhosis;
- •- Diagnosed and/or undergoing treatment for hepatocellular carcinoma;
- •- Awaiting liver transplantation;
- •- Currently engaged in care for treatment of hepatitis C infection, hepatitis B infection or HIV;
- •- Unable or unwilling to present to pick up ongoing DAA supply for treatment (four weekly basis);
- •- Receiving medications which are contra-indicated to co-administration of direct acting antiviral's or at risk of significant drug-drug interactions;
- •- Clients who are first time presenters or users of the medically supervised injecting room
- •- Clients who receive a clinical intervention for overdose whilst using the supervised injecting drug room after initially consenting to participate;
- •- Evidence of any condition, therapy, laboratory abnormality or other circumstance (current or prior) that may confound the study’s results, or interfere with participation for the full duration of the study, such that it is not in the best interest of the participant.
研究者
相似试验
尚未招募
不适用
Point Of Care Hepatitis C testing and subsequent treatment uptake in Addiction Medicine residential withdrawal unit (POCAM): a pilot studyHepatitis C virusInfection - Other infectious diseasesPublic Health - Health service researchACTRN12622000441718St Vincent's Hospital Melbourne100
Enrolling By Invitation
不适用
Screening for Hepatitis C Virus Infection and Assessment of Knowledge and Attitude about The Disease in Adolescents and Young Adultsadolescents and young adults who have risk(s) of HCV infectionHepatitis C virus (HCV), adolescents, young adults, prevalence, sofosbuvir/ velpatasvir, knowledge and attitude, treatment literacyTCTR20221111007Ratchadaphiseksomphot Endowment Fund300
招募中
不适用
Point-of-care Testing for Hepatitis C in the Priority Settings of Mental Health, Prisons and Drug & Alcohol FacilitiesHepatitis CACTRN12621001578897Eliminate C Australia1,500
招募中
不适用
Clinical Validation of a Point of Care (POC) Test for the Measurement of Infliximab (IFX) or Adalimumab (ADL) Levels in the Serum of Inflammatory Bowel Disease (IBD) PatientsNL-OMON20824ProciseDx320
尚未招募
3 期
se of bed side testing of infection in reducing the duration of antibiotic therapyCTRI/2024/06/069211Seth GS Medical College and KEM Hospital
